Skip to main content
Premium Trial:

Request an Annual Quote

Becton Dickinson Said Fiscal Q2 Revenues Climb 9 Percent; Diagnostic Segment Leads Growth

NEW YORK , April 27 (GenomeWeb News) -  Becton Dickinson today reported $1.4 billion in total fiscal second-quarter revenues, a 9-percent increase from the same quarter one year ago.


Revenues were up across BD's Medical, Diagnostics, and Biosciences segments, and BD attributed further revenue increase to foreign currency translation, particularly the euro.


Diagnostics led the growth with a 12-percent increase over the comparable period last year, while Biosciences and medical grew by 9 percent and 8 percent respectively.

R&D spending in the quarter rose to $66 million from $60.2 million in the second quarter of 2004.

Net earnings increased to $188 million, or $.74 per basic share, from $165 million, or $.65 per share, during the second quarter of FY'05.

Cash and cash equivalents were not provided.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.